Stem Cell Therapy for Multiple Sclerosis Market
Stem Cell Therapy for Multiple Sclerosis Market
Scope: Industry Analysis, Market Size, Growth,
Trends Till 2031
Request Sample Report
Stem Cell Therapy for Multiple Sclerosis Market Size and Growth
The global stem cell therapy for multiple sclerosis market is projected to reach $2.5 billion by 2027, with a CAGR of 12.5% during the forecast period. The market is driven by the increasing prevalence of multiple sclerosis and the growing adoption of stem cell therapy as a promising treatment option. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ American CryoStem
◍ Athersys
◍ Celgene Cellular Therapeutics
◍ Cell Cure Neurosciences
The stem cell therapy for multiple sclerosis market is competitive with key players such as American CryoStem, Athersys, Celgene Cellular Therapeutics, and Cell Cure Neurosciences. These companies focus on developing innovative stem cell treatments to address the unmet needs of multiple sclerosis patients. In terms of sales revenue, Athersys reported $25 million in sales in 2020. Celgene Cellular Therapeutics reported $15 million in sales in 2020. Request Sample Report
Market Segmentation
By Application
◍ Relapsing-Remitting Multiple Sclerosis (RRMS)
◍ Primary Progressive Multiple Sclerosis (PPMS)
◍ Secondary Progressive Multiple Sclerosis (SPMS)
◍ Progressive Relapsing Multiple Sclerosis (PRMS)
By Product
◍ Intravenous ◍ Intracerebroventricular
Request Sample Report
Market Growth
Request Sample Report
$ 3.43 Billion
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients